Table 2.
Sample characteristics. This study was conducted July–September 2017, in Chicago, IL.
| Percentage of sample (N = 39) | |
|---|---|
| Gender | |
| Male | 38.5% |
| Female | 61.5% |
| Age | |
| 20–39 years | 12.8% |
| 40–59 years | 35.9% |
| 60–79 years | 48.7% |
| 80 years and older | 2.6% |
| Race and ethnicity | |
| White, Non-Hispanic | 100.0% |
| Fitzpatrick skin type | |
| I | 35.9% |
| II | 28.2% |
| III | 28.2% |
| IV | 7.7% |
| Stage at diagnosis | |
| Melanoma-in-situ | 38.5% |
| Stage IA | 30.8% |
| Stage IB | 17.9% |
| Stage IIA | 10.3% |
| Stage IIB | 2.6% |
| Years elapsed from initial diagnosis | |
| 0–1 | 28.2% |
| 2–3 years | 0.0% |
| 4–6 years | 20.5% |
| 7–9 years | 25.6% |
| 10 years and longer | 25.6% |
| Education | |
| Some post-high school education | 2.6% |
| College graduate | 53.8% |
| Graduate degree | 43.6% |
| Annual household income | |
| $20,000–$34,999 | 2.6% |
| $35,000–$50,999 | 2.6% |
| $51,000–$100,000 | 28.2% |
| Over $100,000 | 66.7% |